Navigation Links
PARI's LC Sprint & TREK S Featured in 'ER' Final Episode on NBC Thursday
Date:3/30/2009

MIDLOTHIAN, Va., March 30 /PRNewswire/ -- PARI Respiratory Equipment's LC Sprint reusable nebulizer and TREK S portable compressor were both used in the filming of the final episode of "ER" that will air Thursday at 9pm on NBC. Numerous stars are reprising roles for the final season of "ER," including George Clooney and Julianna Margulies, so the return of PARI products goes hand in hand - as PARI nebulizers have been used on the show to highlight treatments for a variety of respiratory illnesses.

"We are very pleased that NBC would use the final episode of 'ER' to once again highlight respiratory conditions and therapies. So many Americans suffer from a wide variety of respiratory illnesses and degenerative conditions that it makes sense that writers would use real-life examples and industry-leading nebulizers in their story lines," said Geoff Hunziker, president of PARI Respiratory Equipment.

The LC Sprint is the next generation nebulizer that has been used to deliver aerosol therapies for asthma, COPD, and cystic fibrosis. Combined with PARI's TREK S, the LC Sprint delivers medication treatments averaging between 5 to 6 minutes.

The PARI LC Sprint features breath-enhancement, where a patient's unique breathing pattern controls and optimizes medication delivery to the lungs by means of two valves on the nebulizer. PARI's TREK S is a compact, portable compressor that is powered by a lithium ion battery or used with an AC adaptor.

About PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Maker of the world's leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI
'/>"/>

SOURCE PARI Respiratory Equipment, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Online Rx Price Comparison Tools, Drug Discount Card Use Soars in Weak Economy
2. Anatomist Dr. Gunther von Hagens, Pioneer of Anatomical Exhibitions Not Affiliated With Copycat Display in Paris
3. U.S. Preventive Medicine(R), American Hospital of Paris Sign Affiliation Agreement to Deliver Preventive Medicine Services
4. Arobella Medical CEO Speaks at International Wound Care Conference in Paris
5. Global Med Technologies(R) European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals
6. LOreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008
7. Lierac Paris Expands in the United States at Healthy Skincare Centers at CVS/pharmacy
8. Parisian Peel(R) Introduces Anti-Aging Suffusion System
9. Comparison of anticoagulants for angioplasty show similar outcomes
10. Comparison of antipsychotic treatments in adolescents with schizophrenia
11. Comparison of venlafaxine and SSRIs in the treatment of depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 The Rottenstein Law Group ... has created the Tylenol Lawsuit Information Center at ... users and those who are considering filing lawsuits. ... potentially cause severe liver damage, according to a 2009 ... In the “safety communication,” the FDA warned consumers against ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... have a great deal of control over their level ... their weight, yet far fewer are actually taking that ... International Food Information Council (IFIC) Foundation’s 2013 Food & ... of respondents say it’s possible to have “a great ...
(Date:5/23/2013)... Chicago, IL (PRWEB) May 23, 2013 ... the fifth anniversary of its popular and only free ... and a successful continuing resource for OCD sufferers, the ... anxiety, OCD, and related disorders. This allows group ... Therapy, and Exposure and Response Prevention. , “Participants in ...
(Date:5/23/2013)... (HealthDay News) -- Schools should ensure that kids ... each day to support their health and boost ... Although previous studies show 60 minutes ... and development, it,s estimated that only about 50 ... recommendation, according to the report from the Institute ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) ... as badly as methamphetamine or crack cocaine, a new ... ,meth mouth, or ,coke mouth, it is startling to ... less the same," said Dr. Mohamed Bassiouny, a professor ... Dentistry in Philadelphia. Methamphetamine, crack cocaine and soda ...
Breaking Medicine News(10 mins):Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3
... Scientific understanding and medical treatments for autism spectrum disorders ... but much remains to be done, say experts from ... of Philadelphia who published a scientific review of the ... by autism researchers throughout the world, and give our ...
... , BALTIMORE, Oct. 14 Lynn R. Chincheck, DDS, and ... breast cancer on Sunday, Oct. 18, as part of Baltimore,s ... participate by patients who have battled breast cancer, Team Chincheck ... , "After meeting several patients who have been affected by ...
... Advice Networks , the nation,s leading provider of physician ... track consumer purchase behavior, not just purchase intent, for ... their revenue and justify investments designed to capture market ... their health messages to purchase volume. To address this ...
... Almost a billion people across the planet do not have ... a mere $5 can give one person clean water for ... to doing good and supporting good in communities through a ... bringing clean and safe drinking water to people in developing ...
... Cardium Therapeutics (NYSE Amex: CXM ) today ... product candidate Excellagen(TM), a collagen-based topical gel for use ... in patients with chronic or non-chronic diabetic foot ulcers. ... study findings reported today from the Excellarate(TM) Phase 2b ...
... ... it will feature the latest developments in its advanced DuraHeart™ Left-Ventricular Assist System at ... October 17-21. , ... Ann Arbor, Mich. (PRWEB) -- Terumo Heart, Inc., a wholly owned subsidiary of ...
Cached Medicine News:Health News:Experts summarize state of the science in autism disorders 2Health News:Team Chincheck Goes Miles for Smiles 2Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 2Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 3Health News:Tom's of Maine and charity: water Team Up to Fund Global Clean Water Projects With Instant, Mobile Donation Campaign 2Health News:Tom's of Maine and charity: water Team Up to Fund Global Clean Water Projects With Instant, Mobile Donation Campaign 3Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 2Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 3Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 4Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 5Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 6Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 7Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 8Health News:DuraHeart™ Third-Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio-thoracic Surgery 2Health News:DuraHeart™ Third-Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio-thoracic Surgery 3
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation ... global medical technology company, today scheduled a conference call ... of fiscal year 2013, ended April 30, 2013. The ... May 30, 2013. The Company will report financial results ... the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... 23, 2013  The need to add tissue ... was highlighted prominently at the 108 th ... in San Diego.  According to SonaCare Medical, a ... (HIFU) technology, the need for image-guided technologies to ... to consider minimally invasive ablative treatments, was addressed ...
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... 17, 2007 - ProNAi Therapeutics,Inc., a biopharmaceutical ... based on DNA interference (DNAi), today,announced that ... demonstrated preclinical in vivo efficacy in,xenograft mice ... including curative,events for difficult-to-treat Burkitt's Lymphoma., Dr. ...
... April 17, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. announced ... 2 clinical trial of the triplet combination ... in the,first-line treatment of advanced non-small cell ... clinically significant,improvement in both progression-free survival and ...
Cached Medicine Technology:ProNAi Announces Preclinical Success for PNT2258 Therapeutic -,Curative Events in Xenograft Mice for Difficult-to-Treat,Non-Hodgkin's Lymphoma 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 3Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 4
... The Macula Plus® 5.5 ... observation of the optic ... Use it with your ... detecting choroidal neovascular membranes, ...
... iQ200 Automated Urine Microscopy Analyzer (iQ200) ... (APR) software to classify urine particles ... results. The iQ200 eliminates most technologist ... particle images by automating specimen preparation, ...
... is based on the C6 peptide antigen, a ... VlsE. This peptide has been shown to ... all of the antigenic reactivity of the whole ... C6 peptide is a sensitive and specific marker ...
First to USA-market, this revolutionary technology combines CBC and CRP analysis for stat results of 17 parameters within 4.5 minutes!...
Medicine Products: